Literature DB >> 19651824

An overview of autologous chondrocyte implantation.

P D Gikas1, L Bayliss, G Bentley, T W R Briggs.   

Abstract

Chondral damage to the knee is common and, if left untreated, can proceed to degenerative osteoarthritis. In symptomatic patients established methods of management rely on the formation of fibrocartilage which has poor resistance to shear forces. The formation of hyaline or hyaline-like cartilage may be induced by implanting autologous, cultured chondrocytes into the chondral or osteochondral defect. Autologous chondrocyte implantation may be used for full-thickness chondral or osteochondral injuries which are painful and debilitating with the aim of replacing damaged cartilage with hyaline or hyaline-like cartilage, leading to improved function. The intermediate and long-term functional and clinical results are promising. We provide a review of autologous chondrocyte implantation and describe our experience with the technique at our institution with a mean follow-up of 32 months (1 to 9 years). The procedure is shown to offer statistically significant improvement with advantages over other methods of management of chondral defects.

Entities:  

Mesh:

Year:  2009        PMID: 19651824     DOI: 10.1302/0301-620X.91B8.21824

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  24 in total

1.  Five-year results of arthroscopic techniques for the treatment of acetabular chondral lesions in femoroacetabular impingement.

Authors:  Donato Mancini; Andrea Fontana
Journal:  Int Orthop       Date:  2014-06-21       Impact factor: 3.075

2.  The role of rehabilitation following autologous chondrocyte implantation: a retrospective chart review.

Authors:  Jenny L Toonstra; Jennifer S Howard; Timothy L Uhl; Robert A English; Carl G Mattacola
Journal:  Int J Sports Phys Ther       Date:  2013-10

3.  The role of tissue engineering in articular cartilage repair and regeneration.

Authors:  Lijie Zhang; Jerry Hu; Kyriacos A Athanasiou
Journal:  Crit Rev Biomed Eng       Date:  2009

4.  Interaction between osteoarthritic chondrocytes and adipose-derived stem cells is dependent on cell distribution in three-dimension and transforming growth factor-β3 induction.

Authors:  Janice H Lai; Heather Rogan; Glen Kajiyama; Stuart B Goodman; R Lane Smith; William Maloney; Fan Yang
Journal:  Tissue Eng Part A       Date:  2015-02-06       Impact factor: 3.845

Review 5.  Biomechanical outcomes of cartilage repair of the knee.

Authors:  Carmen E Quatman; Joshua D Harris; Timothy E Hewett
Journal:  J Knee Surg       Date:  2012-07       Impact factor: 2.757

6.  Autologous chondrocyte implantation for the treatment of chondral and osteochondral defects of the talus: a meta-analysis of available evidence.

Authors:  Philipp Niemeyer; Gian Salzmann; Hagen Schmal; Hermann Mayr; Norbert P Südkamp
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-10-30       Impact factor: 4.342

7.  Combined autologous chondrocyte implantation (ACI) with supra-condylar femoral varus osteotomy, following lateral growth-plate damage in an adolescent knee: 8-year follow-up.

Authors:  Sridhar Vijayan; George Bentley
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2011-03-18

8.  Ten-year clinical and radiographic outcomes after autologous chondrocyte implantation of femoral condyles.

Authors:  David Martinčič; Damjan Radosavljevič; Matej Drobnič
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-21       Impact factor: 4.342

9.  Patient Experiences of Recovery After Autologous Chondrocyte Implantation: A Qualitative Study.

Authors:  Jenny L Toonstra; Dana Howell; Robert A English; Christian Lattermann; Carl G Mattacola
Journal:  J Athl Train       Date:  2016-11-11       Impact factor: 2.860

10.  Disparate response of articular- and auricular-derived chondrocytes to oxygen tension.

Authors:  Thomas J Kean; Hisashi Mera; G Adam Whitney; Danielle L MacKay; Amad Awadallah; Russell J Fernandes; James E Dennis
Journal:  Connect Tissue Res       Date:  2016-04-29       Impact factor: 3.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.